Literature DB >> 24679424

Distal cholangiocarcinoma.

Paxton V Dickson1, Stephen W Behrman2.   

Abstract

Cholangiocarcinoma involving the distal common bile duct (distal cholangiocarcinoma [DCC]) is a periampullary neoplasm that is less common than, but often difficult to distinguish from, pancreatic adenocarcinoma (PDA). The prognosis and cure rate of DCC is improved over that of PDA, but it remains a highly lethal disease. Although the diagnostic and therapeutic management of DCC is not dissimilar from PDA, the pathophysiology is, in many instances, distinctly different. A multi-disciplinary approach toward DCC is important.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adjuvant therapy; Cholangiocarcinoma; Pathophysiology; Surgery

Mesh:

Substances:

Year:  2014        PMID: 24679424     DOI: 10.1016/j.suc.2013.12.004

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  9 in total

Review 1.  Cholangiocarcinoma.

Authors:  Paul J Brindley; Melinda Bachini; Sumera I Ilyas; Shahid A Khan; Alex Loukas; Alphonse E Sirica; Bin Tean Teh; Sopit Wongkham; Gregory J Gores
Journal:  Nat Rev Dis Primers       Date:  2021-09-09       Impact factor: 65.038

2.  A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.

Authors:  Bobby V M Dasari; Keith J Roberts; James Hodson; Lewis Stevens; Andrew M Smith; Stefan G Hubscher; John Isaac; Paolo Muiesan; Robert P Sutcliffe; Ravi Marudanayagam; Darius F Mirza
Journal:  HPB (Oxford)       Date:  2016-02-24       Impact factor: 3.647

Review 3.  Current and future roles of mucins in cholangiocarcinoma-recent evidences for a possible interplay with bile acids.

Authors:  Elisa Danese; Andrea Ruzzenente; Martina Montagnana; Patricia Marie-Jeanne Lievens
Journal:  Ann Transl Med       Date:  2018-09

4.  Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression.

Authors:  Cuiping Wu; Jinmei Zhang; Xiangang Cao; Qian Yang; Dequan Xia
Journal:  Med Sci Monit       Date:  2016-07-29

5.  Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma.

Authors:  Weiwei Wang; Wei Zhong; Jiahui Yuan; Congcong Yan; Shaoping Hu; Yinping Tong; Yubin Mao; Tianhui Hu; Bing Zhang; Gang Song
Journal:  Oncotarget       Date:  2015-12-08

Review 6.  Genetic analysis in the clinical management of biliary tract cancer.

Authors:  Toshifumi Wakai; Masayuki Nagahashi; Yoshifumi Shimada; Pankaj Prasoon; Jun Sakata
Journal:  Ann Gastroenterol Surg       Date:  2020-04-14

7.  Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.

Authors:  Peng Liao; Li Cao; Hang Chen; Shui-Zi Pang
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

8.  The Impact of Intraoperative Frozen Section on Resection Margin Status and Survival of Patients Underwent Pancreatoduodenectomy for Distal Cholangiocarcinoma.

Authors:  Zhiqiang Chen; Bingran Yu; Jiaping Bai; Qiong Li; Bowen Xu; Zhaoru Dong; Xuting Zhi; Tao Li
Journal:  Front Oncol       Date:  2021-05-03       Impact factor: 6.244

Review 9.  Surgical Treatment of Distal Cholangiocarcinoma.

Authors:  Leva Gorji; Eliza W Beal
Journal:  Curr Oncol       Date:  2022-09-17       Impact factor: 3.109

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.